We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sends Pfizer Untitled Letter for Leaving Risks Out of Promotional Video
FDA Sends Pfizer Untitled Letter for Leaving Risks Out of Promotional Video
The FDA’s Office of Prescription Drug Promotion issued an untitled letter to Pfizer for a misleading direct-to-consumer online video for its Estring (estradiol vaginal ring) treatment for moderate-to-severe painful sex and vaginal discomfort after menopause.